{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:53Z","timestamp":1787032793150,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,16]]},"DOI":"10.7759\/cureus.15059","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T13:02:53Z","timestamp":1621170173000},"source":"Crossref","is-referenced-by-count":1,"title":["All-Cause Mortality and Incidence of Major Adverse Cardiac Events in Sickle Cell Nephropathy: A Comparative Study"],"prefix":"10.7759","author":[{"given":"Kunjan","family":"Udani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayda","family":"Parisio-Poldiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2006.11928171","article-title":"Structure-function relations of human hemoglobins","volume":"19","author":"Marengo-Rowe AJ","year":"2006","unstructured":"Marengo-Rowe AJ. Structure-function relations of human hemoglobins. Proc (Bayl Univ Med Cent). 2006, 19:239-45. 10.1080\/08998280.2006.11928171","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2014.08.004","article-title":"Sickle cell nephropathy","volume":"60","author":"Gargiulo R","year":"2014","unstructured":"Gargiulo R, Pandya M, Seba A, Haddad RY, Lerma EV. Sickle cell nephropathy. Dis Mon. 2014, 60:494-9. 10.1016\/j.disamonth.2014.08.004","journal-title":"Dis Mon"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000241","article-title":"New insights into sickle cell disease: mechanisms and investigational therapies","volume":"23","author":"Kato GJ","year":"2016","unstructured":"Kato GJ. New insights into sickle cell disease: mechanisms and investigational therapies. Curr Opin Hematol. 2016, 23:224-32. 10.1097\/MOH.0000000000000241","journal-title":"Curr Opin Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.795","article-title":"Incidence, demographic characteristics, and geographic distribution of sickle cell trait and sickle cell anemia births in Michigan, 1997-2014","volume":"7","author":"Reeves SL","year":"2019","unstructured":"Reeves SL, Jary HK, Gondhi JP, Kleyn M, Spector-Bagdady K, Dombkowski KJ. Incidence, demographic characteristics, and geographic distribution of sickle cell trait and sickle cell anemia births in Michigan, 1997-2014. Mol Genet Genomic Med. 2019, 7:e795. 10.1002\/mgg3.795","journal-title":"Mol Genet Genomic Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.423","article-title":"Cardiovascular complications in patients with sickle cell disease","volume":"2017","author":"Gladwin MT","year":"2017","unstructured":"Gladwin MT. Cardiovascular complications in patients with sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017, 2017:423-30. 10.1182\/asheducation-2017.1.423","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08853.x","article-title":"Sickle cell nephropathy - a practical approach","volume":"155","author":"Sharpe CC","year":"2011","unstructured":"Sharpe CC, Thein SL. Sickle cell nephropathy - a practical approach. Br J Haematol. 2011, 155:287-97. 10.1111\/j.1365-2141.2011.08853.x","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25263","article-title":"Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease","volume":"93","author":"Xu JZ","year":"2018","unstructured":"Xu JZ, Garrett ME, Soldano KL, Chen ST, Clish CB, Ashley-Koch AE, Telen MJ. Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease. Am J Hematol. 2018, 93:1451-60. 10.1002\/ajh.25263","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.05.045","article-title":"Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis","volume":"48","author":"Sipahi I","year":"2006","unstructured":"Sipahi I, Tuzcu EM, Schoenhagen P, et al.. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol. 2006, 48:833-8. 10.1016\/j.jacc.2006.05.045","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah H","year":"2014","unstructured":"Elmariah H, Garrett ME, De Castro LM, et al.. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol. 2014, 89:530-5. 10.1002\/ajh.23683","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999-2009)","volume":"60","author":"Hamideh D","year":"2013","unstructured":"Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. 2013, 60:1482-6. 10.1002\/pbc.24557","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh CD","year":"2010","unstructured":"Fitzhugh CD, Lauder N, Jonassaint JC, et al.. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol. 2010, 85:36-40. 10.1002\/ajh.21569","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin MT","year":"2012","unstructured":"Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012, 59:1123-33. 10.1016\/j.jacc.2011.10.900","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000213897","article-title":"Cardiorenal risk prevalence in sickle cell hemoglobinopathy","volume":"112","author":"Abo-Zenah H","year":"2009","unstructured":"Abo-Zenah H, Moharram M, El Nahas AM. Cardiorenal risk prevalence in sickle cell hemoglobinopathy. Nephron Clin Pract. 2009, 112:c98-c106. 10.1159\/000213897","journal-title":"Nephron Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694422","article-title":"Elevated D-dimer levels in African Americans with sickle cell trait","volume":"127","author":"Naik RP","year":"2016","unstructured":"Naik RP, Wilson JG, Ekunwe L, et al.. Elevated D-dimer levels in African Americans with sickle cell trait. Blood. 2016, 127:2261-3. 10.1182\/blood-2016-01-694422","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go AS","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351:1296-305. 10.1056\/NEJMoa041031","journal-title":"N Engl J Med"},{"key":"ref16","article-title":"Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis","volume":"31","author":"Diamond JR","year":"1991","unstructured":"Diamond JR. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kid Int. 1991, 31:29-34.","journal-title":"Kid Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross R","year":"1999","unstructured":"Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999, 340:115-26. 10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00143.x","article-title":"Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys","volume":"58","author":"Bank N","year":"2000","unstructured":"Bank N, Kiroycheva M, Singhal PC, Anthony GM, Southan GJ, Szabo C. Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int. 2000, 58:82-9. 10.1046\/j.1523-1755.2000.00143.x","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.V101187","article-title":"Sickle cell nephropathy","volume":"10","author":"Saborio P","year":"1999","unstructured":"Saborio P, Scheinman J. Sickle cell nephropathy. J Am Soc Nephrol. 1999, 10:187-192.","journal-title":"J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000183404","article-title":"Renal lesions in sickle cell nephropathy in children","volume":"39","author":"Tejani A","year":"1985","unstructured":"Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D. Renal lesions in sickle cell nephropathy in children. Nephron. 1985, 39:352-5. 10.1159\/000183404","journal-title":"Nephron"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt OS","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994, 330:1639-44. 10.1056\/NEJM199406093302303","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7727\/wimj.2014.012","article-title":"Clinical factors associated with morbidity and mortality in patients admitted with sickle cell disease","volume":"63","author":"Galloway-Blake K","year":"2014","unstructured":"Galloway-Blake K, Reid M, Walters C, Jaggon J, Lee MG. Clinical factors associated with morbidity and mortality in patients admitted with sickle cell disease. West Indian Med J. 2014, 63:711-6. 10.7727\/wimj.2014.012","journal-title":"West Indian Med J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70469-0","article-title":"Pathophysiology and treatment of stroke in sickle-cell disease: present and future","volume":"5","author":"Switzer JA","year":"2006","unstructured":"Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006, 5:501-12. 10.1016\/S1474-4422(06)70469-0","journal-title":"Lancet Neurol"},{"key":"ref24","article-title":"Myocardial infarction in sickle cell disease","volume":"88","author":"Martin CR","year":"1996","unstructured":"Martin CR, Johnson CS, Cobb C, Tatter D, Haywood LJ. Myocardial infarction in sickle cell disease. J Natl Med Assoc. 1996, 88:428-432.","journal-title":"J Natl Med Assoc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/HPC.0b013e3181668ac3","article-title":"Acute myocardial infarction in sickle cell disease: a systematic review","volume":"7","author":"Pannu R","year":"2008","unstructured":"Pannu R, Zhang J, Andraws R, Armani A, Patel P, Mancusi-Ungaro P. Acute myocardial infarction in sickle cell disease: a systematic review. Crit Pathw Cardiol. 2008, 7:133-8. 10.1097\/HPC.0b013e3181668ac3","journal-title":"Crit Pathw Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/03630269.2016.1224766","article-title":"Renal failure in sickle cell disease: prevalence, predictors of disease, mortality and effect on length of hospital stay","volume":"40","author":"Yeruva SL","year":"2016","unstructured":"Yeruva SL, Paul Y, Oneal P, Nouraie M. Renal failure in sickle cell disease: prevalence, predictors of disease, mortality and effect on length of hospital stay. Hemoglobin. 2016, 40:295-9. 10.1080\/03630269.2016.1224766","journal-title":"Hemoglobin"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.01.004","article-title":"Sickle cell disease-related pediatric medical expenditures in the U.S","volume":"38","author":"Amendah DD","year":"2010","unstructured":"Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med. 2010, 38:S550-6. 10.1016\/j.amepre.2010.01.004","journal-title":"Am J Prev Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21443","article-title":"The cost of health care for patients with sickle cell disease","volume":"84","author":"Ballas SK","year":"2009","unstructured":"Ballas SK. The cost of health care for patients with sickle cell disease. Am J Hematol. 2009, 84:320-2. 10.1002\/ajh.21443","journal-title":"Am J Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21408","article-title":"The cost of health care for children and adults with sickle cell disease","volume":"84","author":"Kauf TL","year":"2009","unstructured":"Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009, 84:323-7. 10.1002\/ajh.21408","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55538-all-cause-mortality-and-incidence-of-major-adverse-cardiac-events-in-sickle-cell-nephropathy-a-comparative-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:29:04Z","timestamp":1707488944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55538-all-cause-mortality-and-incidence-of-major-adverse-cardiac-events-in-sickle-cell-nephropathy-a-comparative-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,16]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.15059","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,16]]}}}